Overview A type of bone growth disorder. Due to genetic mutations, the cartilage does not convert into a bone during fetal ...

BridgeBio Pharma has bounced back from the withdrawal of infigratinib in oncology, linking the molecule to a BioMarin-beating ...

An experimental drug from BridgeBio Pharma helped accelerate growth in height among a dozen people with achondroplasia, the most common cause of disproportionate short stature. The results, from one ...

Mizuho Securities analyst Salim Syed assigned a Buy rating on BridgeBio Pharma (BBIO – Research Report) on June 4 and set a price target ...

The high school sports year has come to a close, but a La Costa Canyon High School freshman swimmer is reshaping what is ...

Today's biotech news update includes a dramatic vote on MDMA therapy, record drug shortages, bad(?) news for Biomarin, and a ...

(Exclusive) She also notes that babies with dwarfism or achondroplasia can have "larger than normal" heads. From a birthing perspective, Liz admits that carrying Leighton was "just more bearable ...

For Andrew Hanna, adapting to changing situations on stage teaches him how to adapt to the many challenges in life. The ...

Bridgebio Pharma Inc.’s data from the phase II study with infigratinib in achondroplasia “swings the pendulum of debate ...

Snacking on chips and salsa seems pretty simple, but if you’re a person with disabilities at a local establishment, and the ...